×

Cholesterol drug wars

5:25 PM ET Tue, 9 June 2015

CNBC's Meg Tirrell reports on a key ruling by an FDA panel on new cholesterol drug Praluent. At least one "Fast Money" trader would rather own Amgen than Regeneron.